Vafidemstat
An overview of the drug Vafidemstat
| Vafidemstat | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Vafidemstat is a novel pharmaceutical drug under investigation for its potential therapeutic effects in various neuropsychiatric disorders. It is classified as a histone deacetylase inhibitor (HDAC inhibitor), which modulates the expression of genes by altering the acetylation status of histones.
Mechanism of Action
Vafidemstat functions primarily as an HDAC inhibitor. By inhibiting histone deacetylases, it increases the acetylation of histone proteins, leading to a more relaxed chromatin structure and increased gene expression. This mechanism is thought to underlie its potential therapeutic effects in neuropsychiatric disorders by modulating the expression of genes involved in neurotransmission, neuroplasticity, and inflammation.
Therapeutic Applications
Vafidemstat is being investigated for its use in treating a variety of neuropsychiatric conditions, including:
The drug's ability to modulate gene expression may help alleviate symptoms associated with these disorders by restoring normal patterns of neuronal activity and connectivity.
Clinical Trials
Vafidemstat is currently undergoing clinical trials to evaluate its safety and efficacy. These trials are designed to assess its impact on symptom severity, cognitive function, and overall quality of life in patients with neuropsychiatric disorders.
Side Effects
As with many HDAC inhibitors, potential side effects of Vafidemstat may include:
Ongoing clinical trials aim to further elucidate the safety profile of Vafidemstat.
Research and Development
The development of Vafidemstat is part of a broader effort to create targeted therapies for complex neuropsychiatric conditions. By focusing on epigenetic modulation, researchers hope to provide more effective treatments with fewer side effects compared to traditional psychotropic medications.
Related Pages
Vafidemstat
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
